Faculty profile

Zabrina Brumme

ResearcherSimon Fraser University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Simon Fraser University directory, so their courses and email address may be missing. Find their university profile.

Zabrina Brumme

Researcher

Health Sciences

Simon Fraser University

Burnaby, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
No publications since 2021.
Principal investigator on 7 research grants (7 CIHR), most recently in 2018.
Supervised 9 trainees who won CIHR awards, most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Hiv Evolution Immune Escape Antiretroviral Therapy Blood Latency Phylogenetics Reservoir

Latest papers

CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study.
BMJ open · 2021
Afri-Can Forum 2 : Johannesburg, South Africa. 16-18 February 2015.
BMC infectious diseases · 2016
Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence.
Proceedings of the National Academy of Sciences of the United States of America · 2014

All 3 publications

Latest funding

Origins and consequences of Persistent Low-Level HIV Viremia During Antiretroviral Therapy
CIHR · 2024 · Supervisor
$210,000
Towards an HIV cure: quantifying, characterizing and understanding the HIV reservoir
CIHR · 2023 · Supervisor
$105,000
Evaluating the durability and cross-reactivity of SARS-CoV-2 immunity elicited by COVID-19 vaccines
CIHR · 2021 · Co-investigator

All 22 grants and awards

3 publications.

CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study.

Costiniuk CT, Singer J, Langlois MA, Kulic I, Needham J, Burchell A, Jenabian MA, Walmsley S, Ostrowski M, Kovacs C, Tan D, Harris M, Hull M, Brumme Z, Brockman M, Margolese S, Mandarino E, Angel JB, Routy JP, Anis AH, Cooper C

BMJ open2021

DOI: 10.1136/bmjopen-2021-054208 PMID: 34916326

Afri-Can Forum 2 : Johannesburg, South Africa. 16-18 February 2015.

Mukudu H, Martinson N, Sartorius B, Coetzee J, Dietrich J, Mokgatswana K, Jewkes R, Gray GE, Dugas M, Béhanzin L, Guédou FA, Gagnon MP, Alary M, Rutakumwa R, Mbonye M, Kiwanuka T, Nakamanya S, Muhumuza R, Nalukenge W, Seeley J, Atujuna M, Wallace M, Brown B, Bekker LG, Newman PA, Harryparsad R, Olivier AJ, Jaspan HB, Wilson D, Dietrich J, Martinson N, Mukudu H, Mkhize N, Morris L, Cianci G, Dinh M, Hope T, Passmore JAS, Gray CM, Henrick BM, Yao XD, Rosenthal KL, the INFANT Study Team, Henrick BM, Yao XD, Drannik AG, Abimiku A, Rosenthal KL, the INFANT Study Team, Chanzu N, Mwanda W, Oyugi J, Anzala O, Mbow M, Jallow S, Thiam M, Davis A, Diouf A, Ndour CT, Seydi M, Dieye TN, Mboup S, Goodier M, Rilley E, Jaye A, Yao XD, Omange RW, Henrick BM, Lester RT, Kimani J, Ball TB, Plummer FA, Rosenthal KL, Béhanzin L, Guédou FA, Geraldo N, Mastétsé EG, Sossa JC, Zannou MD, Alary M, Osawe S, Okpokoro E, Okolo F, Umaru S, Abimiku R, Audu S, Datong P, Abimiku A, Nyange J, Olenja J, Mutua G, Jaoko W, Omosa-Manyonyi G, Farah B, Khaniri M, Anzala O, Cockcroft A, Tonkin K, Girish I, Mhati P, Cunningham A, Andersson N, Farah B, Indangasi J, Jaoko W, Mutua G, Khaniri M, Nyange J, Anzala O, Diphoko T, Gaseitsiwe S, Maiswe V, Iketleng T, Maruapula D, Bedi K, Moyo S, Musonda R, Wainberg M, Makhema J, Novitsky V, Marlink R, Essex M, Okoboi S, Ssali L, Kalibala S, Birungi J, Egessa A, Wangisi J, Okullu LJ, Bakanda C, Obare F, Boer IMSD, Semvua HH, van den Boogaard J, Kiwango KW, Ngowi KM, Nieuwkerk PT, Aarnoutse RE, Kiwelu I, Muro E, Kibiki GS, Datiri R, Choji G, Osawe S, Okpokoro E, Okolo F, Umaru S, Abimiku R, Audu S, Datong P, Abimiku A, Fomsgaard A, Karlsson I, Jensen KJ, Jensen SS, Leo-Hansen C, Jespersen S, Da Silva Té D, Rodrigues CM, da Silva ZJ, Janitzek CM, Gerstoft J, Kronborg G, the WAPHIR Group, Okpokoro E, Osawe S, Daitiri R, Choji G, Umaru S, Okolo F, Datong P, Abimiku A, Emily N, Joyce O, Robert LR, Anzala A, Viljoen K, Wendoh J, Kidzeru E, Karaoz U, Brodie E, Botha G, Mulder N, Gray C, Cameron W, Stintzi A, Jaspan H, for the INFANT study team, Levett PN, Alexander D, Gulzar N, Grewal PS, Poon AFY, Brumme Z, Harrigan PR, Brooks JI, Sandstrom PA, Calvez S, Sanche SE, Scott JK, Swartz L, Kagee A, Lesch A, Kafaar Z, De Wet A, Okpokoro E, Osawe S, Daitiri R, Choji G, Umaru S, Okolo F, Datong P, Abimiku A, Dietrich J, Smith T, Cotton L, Hornschuh S, van der Watt M, Miller CL, Gray G, Smit J, Jaggernath M, Ndung’u T, Brockman M, Kaida A, on behalf of the AYAZAZI study teams, Akolo M, Kimani J, Gelmon L, Chitwa M, Osero J, Cockcroft A, Marokoane N, Kgakole L, Maswabi B, Mpofu N, Ansari U, Andersson N, Nakinobe E, Miiro GM, Zalwango F, Nakiyingi-Miiro J, Kaleebu P, Semwanga JR, Nyanzi E, Musoke SN, Nakinobe E, Miiro G, Mbidde EK, Lutalo T, Kaleebu P, Handema R, Chianzu GP, Thiam M, Diagne-Gueye D, Ndiaye MK, Mbow M, Ndiaye BP, Traore I, Dia MC, Thomas G, Tour-Kane C, Mboup S, Jaye A, Nyanzi E, Mbidde EK, Kaleebu P, Mpendo J, Kimani J, Birungi J, Muyindike W, Kambugu A, Sebastian H, Ray H, Mike C, Bertin KJ, Modest M, Thiam M, Janha O, Davis A, Amambua-Ngwa A, Nwakanma DC, Mboup S, Jaye A, Jespersen S, Hønge BL, Esbjörnsson J, Medina C, Da Silva TÉ D, Correira FG, Laursen AL, Østergaard L, Andersen A, Aaby P, Erikstrup C, Wejse C, for the Bissau HIV Cohort study group, Dieye S, Sarr M, Sy H, Mbodj HD, Ndiaye M, Ndiaye A, Moussa S, Jaye A, Mboup S, Nyombi BM, Shao ER, Chilumba IB, Moyo S, Gaseitsiwe S, Musonda R, Datong P, Inyang B, Osawe S, Izang A, Cole C, Okolo F, Cameron B, Rosenthal K, Gray C, Jaspan H, Abimiku A, the INFANT study team, Seraise B, Andrea-Marobela K, Moyo S, Musonda R, Makhema J, Essex M, Gaseitsiwe S

BMC infectious diseases2016

DOI: 10.1186/s12879-016-1466-6 PMID: 27410689

Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence.

Payne R, Muenchhoff M, Mann J, Roberts HE, Matthews P, Adland E, Hempenstall A, Huang KH, Brockman M, Brumme Z, Sinclair M, Miura T, Frater J, Essex M, Shapiro R, Walker BD, Ndung'u T, McLean AR, Carlson JM, Goulder PJ

Proceedings of the National Academy of Sciences of the United States of America2014

DOI: 10.1073/pnas.1413339111 PMID: 25453107

Something wrong or missing on this profile? Suggest a correction

Zabrina Brumme

Research

Latest papers

Latest funding

CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study.

Afri-Can Forum 2 : Johannesburg, South Africa. 16-18 February 2015.

Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence.

Origins and consequences of Persistent Low-Level HIV Viremia During Antiretroviral Therapy

Towards an HIV cure: quantifying, characterizing and understanding the HIV reservoir

Evaluating the durability and cross-reactivity of SARS-CoV-2 immunity elicited by COVID-19 vaccines

Snack Chat: A Low Barrier, Community-based Knowledge Exchange Initiative

Phylogenetic and phylodynamic analysis of Hepatitis C epidemic in Pakistan

Towards an HIV cure for all: increasing female representation in HIV latency research

Harnessing cross-reactive T cell receptors to eliminate latent HIV reservoirs

Genetic Characterization of the Latent HIV Reservoir Towards its Immune-mediated Elimination

Integrated phylogenetic, molecular and functional analyses of the within-host latent HIV reservoir

The International HIV Adaptation Collaborative: harnessing host and viral genetic data globally for HIV-1 vaccine design

Frequent collaborators

Mark Brockman

Zabrina Brumme

Angela Kaida

Mohammad-Ali Jenabian

Shari Margolese

Sharon Walmsley

Ann Burchell

Darrell Tan

Mohammad-Ali Jenabian

Curtis Cooper

Mario Ostrowski

Jean-Pierre Routy

Mark Hull

Darrell Tan

Jean-Pierre Routy

Michel Alary

Mohammad-Ali Jenabian

Angela Kaida

Marie-Pierre Gagnon

Darrell Tan